1,081 results on '"Mark, Patrick B"'
Search Results
2. The impact of VEGF signalling pathway inhibitors and/or immune checkpoint inhibitors on kidney function over time: a single centre retrospective analysis
3. Socioeconomic deprivation and illness trajectory in the Scottish population after COVID-19 hospitalization
4. Non-adherence to cardiometabolic medication as assessed by LC-MS/MS in urine and its association with kidney and cardiovascular outcomes in type 2 diabetes mellitus
5. Differential Associations of Cystatin C Versus Creatinine-Based Kidney Function With Risks of Cardiovascular Event and Mortality Among South Asian Individuals in the UK Biobank.
6. Sex and the Relationship Between Cardiometabolic Risk Factors and Estimated GFR Decline: A Population-Based Cohort Study
7. Personalised lung cancer risk stratification and lung cancer screening: do general practice electronic medical records have a role?
8. Diagnosis of cardiovascular disease in patients with chronic kidney disease
9. SGLT2 Inhibitor Use in Chronic Kidney Disease: Supporting Cardiovascular, Kidney, and Metabolic Health
10. Special Patient Populations
11. Contributors
12. Special Populations
13. Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort
14. Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitor Trials
15. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
16. Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria
17. Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort
18. The NightLife study — the clinical and cost-effectiveness of thrice-weekly, extended, in-centre nocturnal haemodialysis versus daytime haemodialysis using a mixed methods approach: study protocol for a randomised controlled trial
19. Stopping Versus Continuing Metformin in Patients With Advanced CKD: A Nationwide Scottish Target Trial Emulation Study
20. Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD
21. Impact of acute kidney injury on major adverse cardiovascular events in intensive care survivors
22. Exploring the Underlying Mechanisms Linking Adiposity and Cardiovascular Disease: A Prospective Cohort Study of 404,332 UK Biobank Participants
23. Cardiovascular complications of chronic kidney disease
24. GFR slope as a surrogate marker for future kidney failure
25. Bioimpedance Indices of Fluid Overload and Cardiorenal Outcomes in Heart Failure and Chronic Kidney Disease: a Systematic Review
26. Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study
27. An Analysis of Vascular Access Thrombosis Events From the Proactive IV irOn Therapy in hemodiALysis Patients Trial
28. A multisystem, cardio-renal investigation of post-COVID-19 illness
29. Sex differences in cancer outcomes across the range of eGFR.
30. Clonal Hematopoiesis of Indeterminate Potential and Diabetic Kidney Disease: A Nested Case-Control Study
31. Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021
32. Short- and long-term outcomes of intensive care patients with acute kidney disease
33. Grams ME, Sang Y, Ballew SH, et al, for the Chronic Kidney Disease Prognosis Consortium. Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int. 2018;93:1442–1451
34. Evans M, Grams ME, Sang Y, et al., for the Chronic Kidney Disease Prognosis Consortium. Risk factors for prognosis in patients with severely decreased GFR. Kidney Int Rep. 2018;3:625–637
35. The presence and impact of multimorbidity clusters on adverse outcomes across the spectrum of kidney function
36. Protocol for a randomised controlled trial to investigate the effects of vitamin K2 on recovery from muscle-damaging resistance exercise in young and older adults—the TAKEOVER study
37. Measuring congestion with a non‐invasive monitoring device in heart failure and haemodialysis: CONGEST‐HF
38. Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS‐MI): rationale and design
39. Description and cross-sectional analyses of 25,880 adults and children in the UK National Registry of Rare Kidney Diseases cohort
40. Cardiovascular and Renal Risk Factors and Complications Associated With COVID-19
41. The ViKTORIES trial: A randomized, double-blind, placebo-controlled trial of vitamin K supplementation to improve vascular health in kidney transplant recipients
42. Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort study
43. Three week compared to seven week run-in period length and the assessment of pre-randomization adherence: A study within a trial
44. Heart Failure Hospitalization in Adults Receiving Hemodialysis and the Effect of Intravenous Iron Therapy
45. Genetic epidemiology of SARS-CoV-2 transmission in renal dialysis units – A high risk community-hospital interface
46. Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
47. Effects of Dapagliflozin in Patients with Membranous Nephropathy
48. Hyperkalemia in Chronic Kidney Disease in the New Era of Kidney Protection Therapies
49. A Randomized, Controlled Trial of the Effect of Allopurinol on Left Ventricular Mass Index in Hemodialysis Patients
50. Change in physical activity and its association with decline in kidney function: A UK Biobank‐based cohort study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.